Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
Public ClinicalTrials.gov record NCT00006133. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
OBJECTIVES: I. Determine the effect of oral contraceptives containing low-dose synthetic estrogens and progestins on disease activity in premenopausal women with inactive, stable, or moderate systemic lupus erythematosus (SLE). II. Determine the effect of hormone replacement therapy with conjugated estrogens and progestins on disease activity in postmenopausal women with inactive, stable, or moderate SLE.
Study identification
- NCT ID
- NCT00006133
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 970 participants
Conditions and interventions
Conditions
Interventions
- estradiol Drug
- ethinyl estradiol Drug
- medroxyprogesterone Drug
- norethindrone Drug
Drug
Eligibility (public fields only)
- Age range
- 0 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2000 (Type not available)
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 24, 2005
Started 2000
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama Comprehensive Cancer Center | Birmingham | Alabama | 35294 | — |
| University of California Los Angeles | Los Angeles | California | 90095-6951 | — |
| University of California-San Francisco | San Francisco | California | 94143 | — |
| Pritzker School of Medicine | Chicago | Illinois | 60637 | — |
| Louisiana State University School of Medicine | Shreveport | Louisiana | 71130-3932 | — |
| Johns Hopkins University School of Medicine | Baltimore | Maryland | 21205 | — |
| University of Michigan Health Systems | Ann Arbor | Michigan | 48109 | — |
| Hospital for Joint Diseases | New York | New York | 10003 | — |
| Saint Luke's-Roosevelt Hospital Center | New York | New York | 10019 | — |
| Hospital for Special Surgery | New York | New York | 10021 | — |
| Rheumatology Associates of Long Island | Port Jefferson Station | New York | 11776 | — |
| Montefiore Medical Center | The Bronx | New York | 10467-2490 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27599 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15260 | — |
| University of Texas- Houston Medical School | Houston | Texas | 77030 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00006133, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2005 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00006133 live on ClinicalTrials.gov.